OLD Category: Oncology

Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma

• Cao L et al.,

Interferon Signaling is Diminished with Age and is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer

• Sceneay J et al.,

Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer

• Beck TN et al.,

The tumor microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV positive Diffuse Large B Cell Lymphoma

• Keane C et al.,

Rebalancing protein homeostasis enhances tumor antigen presentation

• Jaeger AM et al.,

Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients

• Zhu GQ et al.,

Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment

• Pileri SA et al.,

Traceless aptamer-mediated isolation of CD8+ T cells for chimeric antigen receptor T-cell therapy

• Kacherovsky N et al.,

Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary Melanomas

• Kwong LN et al.,

Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers

• Liu JF et al.,

High-plex predictive marker discovery for melanoma immunotherapy treated patients using Digital Spatial Profiling

• Toki MI, Merritt CR, Wong PF, Smithy JW, Kluger HM, Syrigos KN, Ong GT, Warren SE, Beechem JM, Rimm DL

Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer

• Tan AHY et al.,